Research Article
Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
Table 4
Base case results (NHS perspective).
| ||||||||||||||||||||||||||||||||||||
SoC: standard of care; QALY: quality adjusted life year; ICUR: incremental cost-utility ratio; ICER: incremental cost-effectiveness ratio. |